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Abstract
Both common variants and rare variants are involved in the etiology of most complex diseases in humans.
Developments in sequencing technology have led to the identification of a high density of rare variant single-
nucleotide polymorphisms (SNPs) on the genome, each of which affects only at most 1% of the population.
Genotypes derived from these SNPs allow one to study the involvement of rare variants in common human
disorders. Here, we propose an association screening approach that treats genes as units of analysis. SNPs within a
gene are used to create partitions of individuals, and inverse-probability weighting is used to overweight genotypic
differences observed on rare variants. Association between a phenotype trait and the constructed partition is then
evaluated. We consider three association tests (one-way ANOVA, chi-square test, and the partition retention
method) and compare these strategies using the simulated data from the Genetic Analysis Workshop 17. Several
genes that contain causal SNPs were identified by the proposed method as top genes.
Background
Rare variants are common on the genome and have long
been speculated to be involved in the etiology of most
human disorders [1]. In the 2000s, a large number of
genome-wide association studies (GWAS) were con-
ducted using relatively more common single-nucleotide
polymorphisms (SNPs) (with minor allele frequency
[MAF] > 5%). Most of the common variants identified
in these studies have borderline odds ratios and can
explain only a small fraction of susceptibility to a disease
[2]. As a result, there has been increasing interest in the
study of rare variants for complex diseases. This concern
has also been fueled by advancements in sequencing
technology. In particular, the availability of such tech-
nology has directly led to the implementation of the
1000 Genomes Project (http://www.1000genomes.org/),
in which 1,000 genomes from individuals of different
ethnic backgrounds were sequenced, consequently lead-
ing to the identification of a large number of rare
variants (SNPs) with MAF < 1% and some very rare var-
iants with MAF < 0.5%. Because of these low MAFs,
association methods developed for common variants
have limited efficiency for mapping rare variants in
population studies. For these methods to have adequate
power to detect individual rare variants, the sample size
needs to increase substantially as the MAF decreases.
It is also more likely for a rare variant to contribute to
the susceptibility of a disease as part of a group of rare
variants in the same gene or pathway. Therefore group-
ing or collapsing rare variants is the most feasible option
to improve efficiency in studying rare variants. Usually,
the grouping is constructed on the basis of functional
relevancy, physical proximity, or both. Once rare var-
iants have been grouped, their genotypic information is
combined, or collapsed, into a usually univariate score,
and the association between the group of rare variants
and the disease is then studied using the association
between the univariate score and the disease traits. See
Asimit and Zeggini [2] and Dering et al. [3] for excellent
reviews of different methods for rare variant association
analysis, including single-marker, multimarker, and
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collapsing genotypic information is to combine single-
SNP statistics.
In this paper, we consider a gene-based association
analysis for rare variants. This is equivalent to grouping
based on the gene affiliation of SNPs. We propose using
a clustering-based method for collapsing genotypic
information of multiple SNPs within each gene. The
clustering is based on an inverse-probability weighted
sum of genotypic differences that highlights the varia-
tion at rare variant loci. Association between the col-
lapsed partition label and the disease traits can then be
readily evaluated using single-marker association meth-
ods, such as one-way analysis of variance (ANOVA), a
chi-square test, and the partition retention method [4,5].
We apply our approach to the simulated data of the
Genetic Analysis Workshop 17 (GAW17) without
knowledge of the simulation models. After the work-
shop, a comparison of our results with the simulation
answers led to interesting observations regarding both
the method and the simulated data. We discuss these
observations in the Results section.
Methods
Data set
The simulated data set of GAW17 is a combination of
real sequence data and simulated phenotypes. An exome
of 3,205 autosomal genes, corresponding to 24,487
SNPs, was selected. Sequences of these SNPs were
obtained from the 1000 Genomes Project on 697 unre-
lated subjects. SNPs with missing values were imputed
using fastPhase. A majority of the SNPs (74%) were rare
variants (MAF < 1%). Two hundred phenotype sets were
simulated based on these common genotype data. Each
simulated unrelated-individual data set has three quanti-
tative trait values (Q1, Q2, Q4) and the Affected status
Y, with 209 case subjects and 488 control subjects. Gene
information and SNP information were provided. Espe-
cially, whenever available, SNPs were labeled as synon-
ymous or nonsynonymous [6].
Gene-based grouping and collapsing of SNP genotypes
We propose to evaluate an individual gene’s association
with disease traits. SNPs within a gene are grouped for
the association analysis. Our main focus is a collapsing
strategy for multiple-SNP genotypes within a gene. We
propose to create partitions of individuals (or observed
genotypes) based on their genotypic differences evalu-
ated by inverse-probability weighted similarity scores. It
is easier to start with considering alleles at a single SNP
locus first. For two individuals, we can count when they
have the same alleles or different alleles. When the
MAF is small, the chance of having a random match for
the major allele is high. On the other hand, if a rare
variant is involved in the etiology of a disease, then the
c a s es u b j e c t sa r em o r el i k e l yt oh a v et h es a m er a r ev a r -
iants than the control subjects are. Therefore for rare
variant association analysis we want to overweight the
allelic or genotypic similarity for the minor alleles but
not that for the major alleles.
We use the inverse-probability weighted similarity
score, as defined in Table 1. This score has a mean
similarity 0, which is also a desirable property. The alle-
lic similarity can be straightforwardly generalized to the
genotypic similarity scores in Table 2. For example, an
individual 1 with genotype aa and an individual 2 with
genotype Aa will have one match (a, a)a n do n em i s -
match (a, A). Because a is the minor allele, the (a, a)
match will dominate the (a, A) mismatch, and these two
individuals will have a high similarity score. Such a
weighting scheme implicitly assumes that individuals
with the same rare variants will be clustered together
for association analysis with the disease outcomes.
We denote the genotypic similarity score between two
individuals i and j at SNP k by sim(i, j; k). For a given
gene G, the similarity between i and j is defined as the
sum of the similarity scores on SNPs within the gene:
sim sim (, ) (, ; ) . ij ijk
kG
=
∈ ∑ (1)
For the 697 individuals, pairwise similarity scores, the
sim(i, j), are evaluated first and are then converted to a
distance measure using the transformation:
dij a ij ( , ) exp[ ( , )], =− sim (2)
where a is a normalizing constant such that the dis-
tance calculated at each gene is bounded by e
20.W e
then apply hierarchical clustering using Ward’s method
[7] and partition individuals into groups by cutting the
hierarchical clustering tree into a prespecified number
of groups (we consider partition sizes of 5 to 10). See
Figure 1 for an example using FLT1.W ea l s ot a k e
advantage of the synonymy information about the SNPs
by carrying out two separate analyses using nonsynon-
ymous SNPs only or every SNP in a gene.
Table 1 Inverse probability similarity measure: allelic
similarity scores
Individual 2 Individual 1
aA
a 1
2 pa
−
−
1
1 pp aa ()
A −
−
1
1 pp aa ()
1
1
2 () − pa
pa is the population frequency of minor allele a.
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After obtaining the partition of individuals, for each
gene we tested the association between the partition
indexes obtained from the SNPs in that particular gene
and the disease phenotypes. For the disease status Y,w e
considered one-way ANOVA, the chi-square test of
independence, and the partition retention method [4].
For continuous-valued disease outcomes Q1, Q2, and
Q4, we considered one-way ANOVA and the partition
retention method.
The partition retention method is based on association
measure I defined between an outcome variable Y and a
partition Π. More specifically,
I
n
n
YY
sn
i i
i
i
=
− () ∑
2
2 /
,
Π
(3)
where ni is the number of individuals in partition ele-
ment i and Yi is the sample mean of element i. Y and
s are the sample mean and the standard deviation of all
n individuals, respectively. Under the null hypothesis, I
asymptotically converges to a weighted sum of chi-
square distributions with 1 degree of freedom and there-
fore has mean 1. The partition retention method is
more robust to sparse partition than the chi-square test
and can be applied to both dichotomous disease status
Table 2 Inverse probability similarity measure: genotypic similarity scores
Individual 2 Individual 1
aa aA AA
aa 2
2 pa
11
21 2 p pp a aa
−
− ()
−
−
1
1 pp aa ()
aA 11
21 2 p pp a aa
−
− ()
1
2
11
1
1
1 22 pp pp aa aa
+
−
⎡
⎣
⎢
⎢
⎤
⎦
⎥
⎥
−
−
⎧
⎨
⎪
⎩ ⎪
⎫
⎬
⎪
⎭ ⎪ () ()
1
1
1
1 2 () () −
−
− p pp a aa
AA −
−
1
1 pp aa ()
1
1
1
1 2 () () −
−
− p pp a aa
2
1
2 () − pa
pa is the population frequency of minor allele a.
Figure 1 Clustering of individuals using nonsynonymous SNPs for FLT1. Each row is a SNP, and each column is an individual. Green vertical
bars indicate case subjects. Genotype aA is plotted in blue, and genotype AA is plotted in white (a is the minor allele); the genotype aa was not
observed. The partitions of the 697 individuals are indicated by dotted lines. Partition element 2 is driven by similarity on SNP C13S431 but not
on the more common SNPs C13S522 and C13S523.
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partition retention method evaluates the amount of
influence a particular gene has on the disease
phenotypes.
p-values for the ANOVA test and the chi-square test
are derived from corresponding asymptotic distributions.
To address the multiple testing issue, we control the
family-wise error rate using the conservative Bonferroni
correction. For the evaluation using the partition reten-
tion I,w es i m p l yc h o s et h et o p0 . 1 %o fg e n e sf o re a c h
trait. A further examination of results from chromosome
4 revealed that, by using a cutoff of the top 0.1%, only
15 of the 200 replicates returned any null gene (a
family-wise type I error rate), which suggests that the
top 0.1% is a reasonable threshold. In practice, we sug-
gest evaluating p-values using permutations and control-
ling the false discovery rate in order to have better
sensitivity to real genetic signals.
Results
B e c a u s ew eh a v e2 0 0s i m u l a t i o ns e t s ,f o re a c hg e n ew e
counted the number of times it was selected (either in
the top 0.1% for I using the partition retention method
or significant by Bonferroni correction for ANOVA and
the chi-square test) for each trait for each method. We
also compared the effects of partition sizes (results not
shown). The significance varied between different parti-
tion sizes, and the partition size that corresponded to
the most significant results also changed from simula-
tion to simulation. Therefore we used the average count
across six partition sizes (from 5 to 10) to rank genes.
By visually examining the average counts (not shown),
we observed that Q1 had strong genetic signals and that
Q2 and Affected status were harder to map. For Q4, the
one-way ANOVA identified many noncausal genes, or
false positives, to which the partition retention method
was relatively more immune.
Figure 2 summarizes the results from the 200 simula-
tions. The top 10 genes for each method and each trait
are plotted by chromosome. Note that for Q2 the top
10 genes are identified less than 25% of the time and
that the six genes that contain “answers” or causal genes
are identified as top genes but with less than 5% prob-
ability, with the exception of VNN1, which is identified
by the partition retention method 22% of the time. Two
genes for Q1 (FLT1 and KDR) are identified in more
than 50% of the simulated replicates. It is interesting to
note that excluding synonymous SNPs led to better
identification of FLT1 and had less effect on identifica-
tion of KDR.
To better understand the “consistent false positives”
problem that arose during GAW17, we studied several
Figure 2 Top ten genes identified by each of the methods and for each of Y, Q1, Q2, and Q4. Ninety-one genes are shown, displayed by
chromosome. Genes with causal SNPs are highlighted (yellow for Q1 and blue for Q2).
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All of them were found to be significantly associated
with multiple causal SNPs. See Table 3 for an example
between the gene OR2T3 on chromosome 1 and a cau-
sal SNP at C13S523.
We further investigated the relation between power to
detect (probability of true positive) and the effect size of
a gene. The effect size for each SNP is provided by
Almasy et al. [6]. For each gene, we define its total effect
size as:
effect MAF
SNP
gi i
ig
=
∈ ∑ b , (4)
where bi is the effect size b used in the simulation
model for SNP i, which is 0 for noncausal SNPs.
Figure 3 plots the frequencies of each gene with causal
genes identified by the best performing method for each
trait against the gene-wise effect size, that is, the one-
way ANOVA with Bonferroni correction for Q1 and Y
and the I from the partition retention method for Q2.
The power of our approach suffers greatly for extreme
rare variants if the effect size does not scale up as MAF
drops.
Discussion and conclusions
In this paper, we propose a novel strategy for gene-
based association analysis for genes with multiple poten-
tially rare variants. The inverse-probability weighted
clustering approach automatically adjusts weights for
rare variants and overweights their genotypic variation
when comparing individuals for an association study.
Individuals are first partitioned on the basis of their
genetic similarity on multiple SNPs in a gene, and this
partition is then used to calculate association between a
gene and a disease trait.
We also considered several association scores and the
effect of including synonymous variants. Different meth-
ods seem to focus on nonoverlapping signals, which
suggests a multimethod approach for future association
studies. From our results, we can conclude that our
method gains power by considering multiple rare var-
iants in a gene, as illustrated in Figure 1 for one of our
identified causal genes. It is probably beneficial to con-
sider synonymous and nonsynonymous SNPs in future
practice. Filtering out synonymous SNPs corresponds to
a weight of 0 being assigned to synonymous SNPs and a
weight of 1 being assigned to nonsynonymous SNPs,
which can be extended to a smoother weighting scheme
as a possible future direction.
For this simulation study, we used asymptotic p-values
and the conservative Bonferonni correction because we
needed to analyze 200 sets of data. In practice, we sug-
gest evaluating p-values using permutations and control-
ling the false discovery rate in order to have better
sensitivity to real genetic signals. Population information
is provided with the simulated data. Some consistent
false positives may have resulted from confounding due
to population admixture. We recommend using existing
methods, such as Eigensoft [8], to adjust for population
stratification in real applications when applying our
method. It should be pointed out that algorithms such
as Eigensoft [8] may convert the original discrete geno-
type data to continuous values, which requires modifica-
tion to the similarity measure defined in Table 1.
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